Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Placebo-Controlled Preliminary Study of the Efficacy, Safety and Tolerability of ST101 Tablets in the Treatment of Alzheimer's Disease

NCT00842673 is registered in ClinicalTrials.gov with Sonexa Therapeutics, Inc. as lead sponsor.

NCT NCT00842673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00842673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Placebo-Controlled Preliminary Study of the Efficacy, Safety and Tolerability of ST101 Tablets in the Treatment of Alzheimer's Disease
Lead sponsor
Sonexa Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
September 30, 2010
Enrollment
168 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease